Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

June 30, 2004

Study Completion Date

April 30, 2008

Conditions
Pancreatic Cancer
Interventions
DRUG

Gemcitabine + Capecitabine

Gemcitabine + Capecitabine

DRUG

Gemcitabine alone

Gemcitabine alone

Trial Locations (18)

3600

Regionalspital, Thun

5001

Kantonspital Aarau, Aarau

8063

City Hospital Triemli, Zurich

20133

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan

64239

Tel-Aviv Sourasky Medical Center, Tel Aviv

80131

Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples

A-1090

Allgemeines Krankenhaus der Stadt Wien, Vienna

CH-4016

Saint Claraspital AG, Basel

CH-4031

Universitatsspital-Basel, Basel

CH-3010

Inselspital, Bern, Bern

CH-2501

Spitalzentrum Biel, Biel

CH-7000

Ratisches Kantons und Regionalspital, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

CH1951

Institut Central des Hopitaux Valaisans, Sion

CH-8091

Oncology Institute of Southern Switzerland, Zurich

UniversitaetsSpital, Zurich

All Listed Sponsors
collaborator

Central European Cooperative Oncology Group

OTHER

lead

Swiss Cancer Institute

OTHER

NCT00030732 - Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter